BRAMESTON

This brand name is authorized in Cyprus, Malta, Singapore

Active ingredients

The drug BRAMESTON contains one active pharmaceutical ingredient (API):

1 Bromocriptine
UNII 3A64E3G5ZO - BROMOCRIPTINE

Bromocriptine is an inhibitor of prolactin secretion and a stimulator of dopamine receptors. The areas of application of bromocriptine are divided into endocrinological and neurological indications.

Read about Bromocriptine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
BRAMESTON Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
G02CB01 Bromocriptine G Genito urinary system and sex hormones → G02 Other gynecologicals → G02C Other gynecologicals → G02CB Prolactine inhibitors
Discover more medicines within G02CB01
N04BC01 Bromocriptine N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BC Dopamine agonists
Discover more medicines within N04BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: MT Medicines Authority Identifier(s): AA084/07301
Country: SG Health Sciences Authority Identifier(s): 09507P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.